ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 244 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,432,000 | -24.0% | 31,690 | -37.1% | 0.40% | -43.4% |
| Q4 2019 | $3,198,000 | +18.8% | 50,411 | -47.2% | 0.70% | -1.3% |
| Q3 2019 | $2,691,000 | +39.8% | 95,508 | +31.5% | 0.71% | +51.2% |
| Q2 2019 | $1,925,000 | +30.1% | 72,636 | -9.9% | 0.47% | +29.8% |
| Q1 2019 | $1,480,000 | +37.4% | 80,643 | -7.0% | 0.36% | +24.3% |
| Q4 2018 | $1,077,000 | -77.3% | 86,696 | -65.0% | 0.29% | -58.6% |
| Q3 2018 | $4,746,000 | +312.3% | 247,549 | +192.5% | 0.70% | +289.5% |
| Q2 2018 | $1,151,000 | – | 84,633 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |